The price-to-earnings ratio for Repligen Corp. (NASDAQ: RGEN) is 616.72x, which is above its average ratio. Moreover, the 36-month beta value for RGEN is 0.95. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 4 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for RGEN is 51.96M and currently, short sellers hold a 8.14% of that float. On July 30, 2024, RGEN’s average trading volume was 729.65K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RGEN) stock’s latest price update
Repligen Corp. (NASDAQ: RGEN)’s stock price has soared by 12.80 in relation to previous closing price of 138.00. Nevertheless, the company has seen a gain of 17.32% in its stock price over the last five trading days. zacks.com reported 2024-07-30 that Repligen (RGEN) came out with quarterly earnings of $0.33 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.53 per share a year ago.
RGEN’s Market Performance
RGEN’s stock has risen by 17.32% in the past week, with a monthly rise of 23.48% and a quarterly drop of -6.31%. The volatility ratio for the week is 5.76% while the volatility levels for the last 30 days are 5.03% for Repligen Corp. The simple moving average for the past 20 days is 22.37% for RGEN’s stock, with a -4.99% simple moving average for the past 200 days.
Analysts’ Opinion of RGEN
Many brokerage firms have already submitted their reports for RGEN stocks, with Deutsche Bank repeating the rating for RGEN by listing it as a “Buy.” The predicted price for RGEN in the upcoming period, according to Deutsche Bank is $155 based on the research report published on June 26, 2024 of the current year 2024.
RGEN Trading at 13.58% from the 50-Day Moving Average
After a stumble in the market that brought RGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.27% of loss for the given period.
Volatility was left at 5.03%, however, over the last 30 days, the volatility rate increased by 5.76%, as shares surge +25.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.19% lower at present.
During the last 5 trading sessions, RGEN rose by +17.06%, which changed the moving average for the period of 200-days by -0.66% in comparison to the 20-day moving average, which settled at $128.81. In addition, Repligen Corp. saw -13.43% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RGEN starting from Hunt Anthony, who purchase 2,000 shares at the price of $124.08 back on Jun 14 ’24. After this action, Hunt Anthony now owns 165,177 shares of Repligen Corp., valued at $248,160 using the latest closing price.
Madaus Martin D, the Director of Repligen Corp., purchase 1,615 shares at $124.94 during a trade that took place back on Jun 14 ’24, which means that Madaus Martin D is holding 4,613 shares at $201,776 based on the most recent closing price.
Stock Fundamentals for RGEN
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.55 for the gross margin
The net margin for Repligen Corp. stands at -0.0. The total capital return value is set at 0.0. Equity return is now at value 0.76, with 0.55 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 14.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.35.
Conclusion
To wrap up, the performance of Repligen Corp. (RGEN) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
